UBS
-
The co-founder of Playtech sold down most of his remaining stake in the UK gambling software developer via an overnight placement on Monday, bagging £337.3m.
-
The European leveraged finance market was disappointed this week when Bain Capital’s and Cinven’s €5.3bn bid for German generic drug firm Stada fell apart.
-
NetLink Trust has kicked off bookbuilding for its up to S$2.7bn ($1.9bn) IPO, set to be Singapore’s largest listing in half a decade, according to a source close to the trade.
-
Roadshows have begun for the IPO of Celltrion Healthcare, the South Korean marketing affiliate of Celltrion, in a deal that can reach W1.008tr ($897m) if priced at the top of the range.
-
Playtech’s founder is selling a major chunk of his stake tonight, for up to £317.9m, after shares in the gaming software developer have surged 20.3% this year.
-
Kyobo Life Insurance Co and Korea Hydro & Nuclear Power Co have mandated banks for new dollar outings.
-
South Korea's Nonghyup Bank is readying investors for its annual dollar bond.
-
UBS has appointed new leadership for its M&A advisory division for Asia Pacific, following the departure of Alison Harding-Jones.
-
Qinghai Provincial Investment Group Co, Guangdong Hengjian Investment Holding Co and China Logistics Property Holdings Co are expected to meet Reg S investors early next week.
-
Europe’s IPO market took a couple of knocks this week when one flotation was pulled and another traded sharply down on its debut, partly because investor sentiment has cooled. But there was still enough vigour in the market to ensure a successful conclusion to the €3bn re-privatisation of Allied Irish Banks (AIB), write John Loh and Jon Hay.
-
Zur Rose Group had a flying start with the launch of its Sfr252m ($259m) IPO on the SIX Swiss Exchange on Thursday, as books were covered within four hours to the full deal size, including the greenshoe.
-
A senior equity capital markets banker has left UBS to become chief financial officer of an internet startup.